While China accounts for less than 10% of PPD’s business now, Simmons said he suspects more clinical studies taking place in China could shift that number. Over time, he said cities like Shanghai and ...
-
-
Recent Updates
- Hong Kong’s Central Draws Luxury Travelers With LANDMARK Celebration
- China: Singapore firm eyes healthcare growth in Shanghai – 75005001
- 2026 W China Annual Gala: A Tale of Two Cities in Shanghai
- China AI Firms Watch as Nvidia Suppliers Prepare for a Possible Huang Exit
- China AI Firms Watch as Nvidia Suppliers Prepare for a Possible Huang Exit
- Nvidia Succession Fears Hit China and Asian AI Supply Chains
- Nvidia Succession Fears Hit China and Asian AI Supply Chains
- Nvidia Succession Fears Hit China and Asian AI Supply Chains
- Hong Kong Regulators Push Tokenized Finance Toward 24-Hour Trading
- Hong Kong Regulators Push Tokenized Finance Toward 24-Hour Trading
Blogroll